Out‐of‐hospital cardiac arrest and differential risk of cardiac and non‐cardiac QT‐prolonging drugs in 37 000 cases

AIMS: Drugs that prolong the QT interval, either by design (cardiac QT‐prolonging drugs: anti‐arrhythmics) or as off‐target effect (non‐cardiac QT‐prolonging drugs), may increase the risk of ventricular arrhythmias and out‐of‐hospital cardiac arrest (OHCA). Risk mitigation measures were instituted,...

Descripción completa

Detalles Bibliográficos
Autores principales: Eroglu, Talip E., Barcella, Carlo A., Blom, Marieke T., Mohr, Grimur H., Souverein, Patrick C., Torp‐Pedersen, Christian, Folke, Fredrik, Wissenberg, Mads, de Boer, Anthonius, Schwartz, Peter J., Gislason, Gunnar H., Tan, Hanno L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291302/
https://www.ncbi.nlm.nih.gov/pubmed/34374122
http://dx.doi.org/10.1111/bcp.15030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291302/
https://www.ncbi.nlm.nih.gov/pubmed/34374122
http://dx.doi.org/10.1111/bcp.15030

Ejemplares similares